Why AngioDynamics Stock Popped, Then Dropped Today
Source: Motley Fool
2025-07-15 16:42:14 ET
Tuesday started off well for AngioDynamics (NASDAQ: ANGO) , maker of such medical devices as the NanoKnife tool for "electrocuting" cancer, as well as multiple devices for treating peripheral vascular disease. In the morning, AngioDynamics reported stronger-than-expected Q4 2025 sales and earnings, with sales of $80.2 million and an adjusted loss of $0.03 per share (instead of the $0.12-per-share forecast).
By the end of the day, however, the rally fell completely apart. AngioDynamics ended up closing down almost 10% for the day. So what went wrong?
Image source: Getty Images.
AngioDynamics Inc.
NASDAQ: ANGO
ANGO Trading
-0.05% G/L:
$10.945 Last:
84,906 Volume:
$11 Open:
ANGO Latest News
February 27, 2026 03:57:23 pm
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
February 23, 2026 04:30:00 pm
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
February 19, 2026 08:30:00 am
AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform
February 05, 2026 08:00:00 am
AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care
ANGO Stock Data
$455,039,941
38,744,343
2.99%
58
N/A
Medical Equipment & Supplies
Healthcare
US
Latham
